Although no significant difference was observed in IFN-γ levels between the two groups (Fig. 4a), IL-17A was significantly higher in RRMS patients with high Sema4A levels (p = 0.0414) (Fig. 4b). This evidence concerns the gene IFNG and relapsing-remitting multiple sclerosis.